111 related articles for article (PubMed ID: 36455835)
1. Activation of progesterone receptor is essential for folic acid-regulated cancer cell proliferation and migration.
Wang HC; Huo YN; Lee WS
J Nutr Biochem; 2023 Feb; 112():109205. PubMed ID: 36455835
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor activation is required for folic acid-induced anti-proliferation in colorectal cancer cell lines.
Kuo CT; Lee WS
Cancer Lett; 2016 Aug; 378(2):104-10. PubMed ID: 27233474
[TBL] [Abstract][Full Text] [Related]
3. Folic acid prevents the progesterone-promoted proliferation and migration in breast cancer cell lines.
Wang HC; Huo YN; Lee WS
Eur J Nutr; 2020 Sep; 59(6):2333-2344. PubMed ID: 31502059
[TBL] [Abstract][Full Text] [Related]
4. Folic acid inhibits colorectal cancer cell migration.
Ting PC; Lee WR; Huo YN; Hsu SP; Lee WS
J Nutr Biochem; 2019 Jan; 63():157-164. PubMed ID: 30393128
[TBL] [Abstract][Full Text] [Related]
5. Effects of female sex hormones on folic acid-induced anti-angiogenesis.
Lee WS; Lu YC; Kuo CT; Chen CT; Tang PH
Acta Physiol (Oxf); 2018 Apr; 222(4):e13001. PubMed ID: 29178430
[TBL] [Abstract][Full Text] [Related]
6. Intracellular Progesterone Receptor and cSrc Protein Working Together to Regulate the Activity of Proteins Involved in Migration and Invasion of Human Glioblastoma Cells.
Bello-Alvarez C; Moral-Morales AD; González-Arenas A; Camacho-Arroyo I
Front Endocrinol (Lausanne); 2021; 12():640298. PubMed ID: 33841333
[TBL] [Abstract][Full Text] [Related]
7. Folic acid inhibits endothelial cell migration through inhibiting the RhoA activity mediated by activating the folic acid receptor/cSrc/p190RhoGAP-signaling pathway.
Hou TC; Lin JJ; Wen HC; Chen LC; Hsu SP; Lee WS
Biochem Pharmacol; 2013 Feb; 85(3):376-84. PubMed ID: 23178654
[TBL] [Abstract][Full Text] [Related]
8. Folic acid inhibits endothelial cell proliferation through activating the cSrc/ERK 2/NF-κB/p53 pathway mediated by folic acid receptor.
Lin SY; Lee WR; Su YF; Hsu SP; Lin HC; Ho PY; Hou TC; Chou YP; Kuo CT; Lee WS
Angiogenesis; 2012 Dec; 15(4):671-83. PubMed ID: 22843228
[TBL] [Abstract][Full Text] [Related]
9. Progesterone signals through membrane progesterone receptors (mPRs) in MDA-MB-468 and mPR-transfected MDA-MB-231 breast cancer cells which lack full-length and N-terminally truncated isoforms of the nuclear progesterone receptor.
Pang Y; Thomas P
Steroids; 2011 Aug; 76(9):921-8. PubMed ID: 21291899
[TBL] [Abstract][Full Text] [Related]
10. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
11. [Functional study of progesterone receptor isoforms in endometrial cancer cell lines].
Lu Y; Liao QP; Chen CL; Yu L
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 38(5):475-9. PubMed ID: 17068617
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor inhibits proliferation of human breast cancer cells via induction of MAPK phosphatase 1 (MKP-1/DUSP1).
Chen CC; Hardy DB; Mendelson CR
J Biol Chem; 2011 Dec; 286(50):43091-102. PubMed ID: 22020934
[TBL] [Abstract][Full Text] [Related]
13. Progesterone receptor (PR) polyproline domain (PPD) mediates inhibition of epidermal growth factor receptor (EGFR) signaling in non-small cell lung cancer cells.
Kawprasertsri S; Pietras RJ; Marquez-Garban DC; Boonyaratanakornkit V
Cancer Lett; 2016 May; 374(2):279-91. PubMed ID: 26892043
[TBL] [Abstract][Full Text] [Related]
14. Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.
Wei M; He Q; Yang Z; Wang Z; Zhang Q; Liu B; Gu Q; Su L; Yu Y; Zhu Z; Zhang G
BMC Cancer; 2014 Jan; 14():10. PubMed ID: 24401087
[TBL] [Abstract][Full Text] [Related]
15. Activation of membrane progesterone receptor-alpha increases proliferation, migration, and invasion of human glioblastoma cells.
González-Orozco JC; Hansberg-Pastor V; Valadez-Cosmes P; Nicolas-Ortega W; Bastida-Beristain Y; Fuente-Granada M; González-Arenas A; Camacho-Arroyo I
Mol Cell Endocrinol; 2018 Dec; 477():81-89. PubMed ID: 29894708
[TBL] [Abstract][Full Text] [Related]
16. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
17. Folic Acid-Functionalized Nanomedicine: Folic Acid Conjugated Copolymer and Folate Receptor Interactions Disrupt Receptor Functionality Resulting in Dual Therapeutic Anti-Cancer Potential in Breast and Prostate Cancer.
DeCarlo A; Malardier-Jugroot C; Szewczuk MR
Bioconjug Chem; 2021 Mar; 32(3):512-522. PubMed ID: 33556240
[TBL] [Abstract][Full Text] [Related]
18. Folic acid inhibits nasopharyngeal cancer cell proliferation and invasion via activation of FRα/ERK1/2/TSLC1 pathway.
Liu Z; Jin X; Pi W; Liu S
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29070520
[TBL] [Abstract][Full Text] [Related]
19. Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway.
Zuo L; Li W; You S
Breast Cancer Res; 2010; 12(3):R34. PubMed ID: 20540763
[TBL] [Abstract][Full Text] [Related]
20. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
